W. Engelen

644 total citations
9 papers, 156 citations indexed

About

W. Engelen is a scholar working on Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism and Biochemistry. According to data from OpenAlex, W. Engelen has authored 9 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nutrition and Dietetics, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Biochemistry. Recurrent topics in W. Engelen's work include Magnesium in Health and Disease (4 papers), Antioxidant Activity and Oxidative Stress (3 papers) and Vitamin C and Antioxidants Research (2 papers). W. Engelen is often cited by papers focused on Magnesium in Health and Disease (4 papers), Antioxidant Activity and Oxidative Stress (3 papers) and Vitamin C and Antioxidants Research (2 papers). W. Engelen collaborates with scholars based in Belgium and Canada. W. Engelen's co-authors include I. De Leeuw, Jan Vertommen, Christophe De Block, Luc Van Gaal, Begoña Manuel y Keenoy, Marc van der Planken, M.E. de Broe, Jean‐Louis Bosmans, Gert A. Verpooten and Zwi Berneman and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Nutrition and Diabetes & Metabolism.

In The Last Decade

W. Engelen

9 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Engelen Belgium 6 56 24 23 22 21 9 156
Erick McNair Canada 11 44 0.8× 101 4.2× 7 0.3× 21 1.0× 74 3.5× 27 336
Daniel Schurr Israel 8 26 0.5× 60 2.5× 16 0.7× 26 1.2× 36 1.7× 18 215
Rosario D’Anna Italy 9 49 0.9× 98 4.1× 23 1.0× 26 1.2× 28 1.3× 13 660
O Cerná Czechia 9 61 1.1× 10 0.4× 8 0.3× 30 1.4× 4 0.2× 20 192
F. Schouten Netherlands 8 59 1.1× 37 1.5× 16 0.7× 12 0.5× 37 1.8× 16 440
Mohammed Azharuddin United Kingdom 5 47 0.8× 58 2.4× 11 0.5× 13 0.6× 3 0.1× 9 166
Ågot Lia Amundsen Norway 8 74 1.3× 90 3.8× 7 0.3× 23 1.0× 50 2.4× 9 335
Alberto B. Alonso United States 10 49 0.9× 99 4.1× 8 0.3× 5 0.2× 88 4.2× 14 306
JT Judd United States 7 85 1.5× 30 1.3× 24 1.0× 122 5.5× 25 1.2× 9 345
Verónica Escurriol Spain 7 73 1.3× 64 2.7× 19 0.8× 65 3.0× 26 1.2× 9 341

Countries citing papers authored by W. Engelen

Since Specialization
Citations

This map shows the geographic impact of W. Engelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Engelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Engelen more than expected).

Fields of papers citing papers by W. Engelen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Engelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Engelen. The network helps show where W. Engelen may publish in the future.

Co-authorship network of co-authors of W. Engelen

This figure shows the co-authorship network connecting the top 25 collaborators of W. Engelen. A scholar is included among the top collaborators of W. Engelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Engelen. W. Engelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Engelen, W., Begoña Manuel‐y‐Keenoy, Jan Vertommen, I. De Leeuw, & L. Van Gaal. (2005). Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitus. Diabetes & Metabolism. 31(2). 197–204. 3 indexed citations
2.
Leeuw, I. De, W. Engelen, Christophe De Block, & Luc Van Gaal. (2004). Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm).. PubMed. 17(2). 109–14. 31 indexed citations
3.
Engelen, W., et al.. (2003). Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients. Clinical Nephrology. 60(8). 119–124. 38 indexed citations
4.
Keenoy, Begoña Manuel y, Honglei Shen, W. Engelen, et al.. (2001). Long-Term Pharmacologic Doses of Vitamin E Only Moderately Affect the Erythrocytes of Patients with Type 1 Diabetes Mellitus. Journal of Nutrition. 131(6). 1723–1730. 11 indexed citations
5.
Engelen, W., Begoña Manuel y Keenoy, Jan Vertommen, & I. De Leeuw. (2000). Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes. American Journal of Clinical Nutrition. 72(5). 1142–1149. 26 indexed citations
6.
7.
Engelen, W., et al.. (2000). Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?. PubMed. 13(3). 197–203. 16 indexed citations
8.
Leeuw, I. De, et al.. (1998). Effect of intensive magnesium supplementation on the in vitro oxidizability of LDL and VLDL in Mg-depleted type 1 diabetic patients.. PubMed. 11(3). 179–82. 2 indexed citations
9.
Leeuw, I. De, et al.. (1997). Effect of intensive i.v. + oral magnesium supplementation on circulating ion levels, lipid parameters and metabolic control in Mg-depleted insulin-dependent diabetic patients (IDDM).. PubMed. 10(2). 135–41. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erick McNair Breakdown of academic impact, for papers by Daniel Schurr Breakdown of academic impact, for papers by Rosario D’Anna Breakdown of academic impact, for papers by O Cerná Breakdown of academic impact, for papers by F. Schouten Breakdown of academic impact, for papers by Mohammed Azharuddin Breakdown of academic impact, for papers by Ågot Lia Amundsen Breakdown of academic impact, for papers by Alberto B. Alonso Breakdown of academic impact, for papers by JT Judd Breakdown of academic impact, for papers by Verónica Escurriol
Rankless by CCL
2026